Lumatix Biotech

Lumatix Biotech

Pre-clinical
Munich, GermanyFounded 2019lumatix.bio

Lumatix Biotech – Innovative Light-Controlled Affinity Chromatography – Discover how Lumatix is transforming affinity chromatography with cutting-edge light-controlled chromatography technology. Enable precise, pH-neutral antibody purification, improve yield, protect sensitive molecules, and streamline bioprocessing with our advanced solutions.

Founded
2019
Focus
OncologyCell Therapy

About

Lumatix Biotech – Innovative Light-Controlled Affinity Chromatography – Discover how Lumatix is transforming affinity chromatography with cutting-edge light-controlled chromatography technology. Enable precise, pH-neutral antibody purification, improve yield, protect sensitive molecules, and streamline bioprocessing with our advanced solutions.

Funding History

2

Total raised: $15M

Series A$12MUndisclosedNov 15, 2022
Seed$3MHigh-Tech GründerfondsMar 15, 2020

Company Info

TypePrivate
Founded2019
LocationMunich, Germany
StagePre-clinical
SIMILAR COMPANIES
300Microns
300Microns
Pre-clinical · Munich
BetaSense
BetaSense
Pre-clinical · Berlin
AB Diagnostic Systems
AB Diagnostic Systems
Pre-clinical · Jena
bbi-biotech
bbi-biotech
Pre-clinical · Berlin
Mireca Medicines
Mireca Medicines
Pre-clinical · Munich
Is this your company?

Claim your profile to update information, add pipeline data, and connect with investors.

Claim profile